Molecular chaperone HspB2 inhibited pancreatic cancer cell proliferation via activating p53 downstream gene RPRM,

Ze Yu1, Hao Wang1, Yilin Fang1

  • 1Key Laboratory of Saline-alkali Vegetation Ecology Restoration, Ministry of Education, College of Life Science, Northeast Forestry University, Harbin, China.

Insights

Heat shock protein B2 (HspB2) inhibits pancreatic cancer cell proliferation by interacting with mutant p53. This interaction upregulates tumor suppressor genes, offering a potential new treatment strategy for pancreatic cancer.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Heat shock proteins (HSPs) are molecular chaperones crucial for protein quality control, cell cycle regulation, and apoptosis.
  • HspB2 is often inactive in pancreatic cancer, with limited research on its role in cancer cells.
  • Pancreatic cancer remains a significant health challenge with a need for novel therapeutic strategies.

Purpose of the Study:

  • To investigate the role of HspB2 in pancreatic cancer.
  • To elucidate the relationship between HspB2 and p53 in pancreatic cancer cells.
  • To explore HspB2 as a potential therapeutic target for pancreatic cancer.

Main Methods:

  • Investigated HspB2 expression in pancreatic cancer cells (Panc-1).
  • Examined the interaction between HspB2 and mutant p53 (mut-p53).
  • Analyzed the downstream effects on p53 target genes (RPRM, BAI-1, TSAP6) and cellular processes like proliferation and angiogenesis.

Main Results:

  • HspB2 significantly inhibited cell proliferation in Panc-1 cells.
  • HspB2 was found to bind to mut-p53, altering its DNA-binding capabilities.
  • Upregulation of wt-p53 downstream genes (RPRM, BAI-1, TSAP6) was observed, contributing to anti-proliferative and anti-angiogenic effects.

Conclusions:

  • HspB2 plays a critical role in suppressing pancreatic cancer cell proliferation.
  • The interaction between HspB2 and mut-p53 is a key mechanism driving these anti-cancer effects.
  • Targeting the HspB2-p53 pathway presents a promising novel treatment strategy for pancreatic cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.1K